Feasibility Study and Pilot Hybrid Effectiveness-Implementation Trial for the Universal Prevention of Maternal Perinatal Mental Disorders as Normalized Routine Practice (e-Perinatal Pilot)

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Seville

About this trial

This study is part of the e-Perinatal project, funded by the European Research Council. This research project will follow the first three phases recommended by the Medical Research Council (MRC) framework for the development and evaluation of complex interventions (Skivington et al., 2021).

The primary aim is to evaluate the feasibility and acceptability of implementing an innovative, personalized mobile health (mHealth) intervention designed for the universal prevention of perinatal mental disorders. Using a pilot, two-arm, cluster-randomized hybrid type 1 clinical trial, the study will assess key implementation outcomes and preliminary effectiveness indicators. The findings will inform the design of a future large clinical trial, intending to evaluate the effectiveness, cost-effectiveness, and implementation of the intervention as part of maternal care.

Eligibility criteria

Qualifiers

Must receive an invitation to participate from a healthcare professional at one of the participating primary healthcare centers

Must be pregnant for at least 16 weeks or have given birth within the last 5 months at the time of enrollment

Must be at least 18 years old

Must have access to a mobile phone and internet connection

Disqualifiers

Meet diagnostic criteria for anxiety or depression, as determined by a structured clinical interview

Be on a waiting list or currently receiving psychological or pharmacological treatment for any mental health or substance use condition

There are no exclusion criteria for partners

Trial design

Treatments tested in this trial

  • e-Perinatal personalized mHealth intervention integrated into routine maternal care
  • Standard routine maternal care with general perinatal health information

Treatment groups

96 Participants
are divided into 2 treatment groups

Sponsors and collaborators

University of Seville

Lead sponsor

Health Service of Andalucia

Collaborator

Junta de Andalucia

Collaborator